What’s going on with the Australian Clinical Labs (ASX:ACL) share price lately?

Here’s what’s been driving the company’s stock this month

| More on:
young female doctor with digital tablet looking confused.

Image source: Getty Images

The Australian Clinical Labs Ltd (ASX: ACL) share price is tumbling today, but it’s had a whopping run lately.

At the time of writing, the Australian Clinical Labs share price is $5.87. That’s 1.51% lower than its previous close but 38% higher than it was at the end of last month.

Additionally, it reached a new 52-week high in yesterday’s session, hitting $6.39 in intraday trade.

Let’s take a look at what’s been driving the company’s stock lately.

Australian Clinical Labs share price soars in December

Australian Clinical Labs’ stock took off last week after the company upgraded its guidance for the first half of financial year 2022 (FY22).

It now expects to bring in between $497.3 million and $517.2 million of revenue and net profits after tax of $116.3 million to $128 million.

The boosted expectations followed continuous strong demand for COVID-19 testing, particularly in New South Wales and Victoria. The company’s revenue is also being helped along by the resilience of its non-COVID business.

The company’s CEO Melinda McGrath commented on the company’s new outlook, saying:

We anticipate heightened volumes of COVID-19 testing to continue during the remainder of FY22 due to the impact of new variants and outbreaks, the lifting of travel restrictions and increased demand for both commercial and travel testing.

Thus, this week’s case numbers might have brought the stock some extra attention.

Over the 7 days to 8pm last night, New South Wales had reported 52,775 new cases of COVID-19. Of those, 12,226 were recorded in the previous 24 hours.

Victoria also announced a new record number of new daily cases today, with 5,137 of the state’s residents testing positive for the virus.

While the month so far has been a good one for the Australian Clinical Labs share price, today seems to be telling a different story. The company’s stock is tumbling for no obvious reason this morning.

However, despite the slump, it’s still in the long-term green. Right now, the Australian Clinical Labs share price is 72% higher than it was at the start of 2021.

Additionally, it isn’t alone in its recent gains. Fellow pathology companies, Healius Ltd (ASX: HLS) and Sonic Healthcare Limited (ASX: SHL) have seen their share prices increase 13% and 9% respectively this month.

Should you invest $1,000 in Australian Clinical Labs right now?

Before you consider Australian Clinical Labs, you'll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Australian Clinical Labs wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of January 13th 2022

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Australian Clinical Labs Limited and Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

a doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
Healthcare Shares

What’s going on with the Polynovo share price today?

The strong start has dissipated for Polynovo shares...

Read more »

a doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
Healthcare Shares

Virtus share price holds steady despite 30% earnings fall

Shareholders are staying loyal with a looming acquisition.

Read more »

a medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Earnings Results

Avita Medical share price tumbles 7% on declining Q1 revenue

The ASX healthcare share saw its net loss for the quarter increase 58% year-on-year.

Read more »

ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance
Healthcare Shares

Own Medibank shares? Here’s what to watch over the coming months

What are the key dates for Medibank in 2022?

Read more »

A happy woman smiles as she looks at a tablet in a room with green plantlife around her. She is also wearing a green shirt representing the rising Polynovo share price
Share Gainers

Why is the Polynovo share price surging 35% in 5 days?

Polynovo shares have sprouted shoots of green in recent weeks.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Rhythm Biosciences share price lifts 5% on TGA news

The company is hoping to market and sell its cancer test kit in Australia this year.

Read more »

a medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Mergers & Acquisitions

CSL share price cracks under Vifor Pharma acquisition delay

Regulatory delays are causing concern...

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

What is driving the CSL share price higher today?

CSL shares are having a good day...

Read more »